PCMI
BIOL
Princeton Capital Management Inc’s Biolase, Inc. BIOL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $18K | Sell |
30,150
-90,980
| -75% | -$54.3K | 0.01% | 68 |
|
|
2017
Q2 | $117K | Sell |
121,130
-4,795
| -4% | -$4.63K | 0.07% | 65 |
|
|
2017
Q1 | $170K | Hold |
125,925
| – | – | 0.11% | 60 |
|
|
2016
Q4 | $176K | Sell |
125,925
-39,494
| -24% | -$55.2K | 0.12% | 61 |
|
|
2016
Q3 | $289K | Sell |
165,419
-135,410
| -45% | -$237K | 0.19% | 64 |
|
|
2016
Q2 | $352K | Sell |
300,829
-4
| -0% | -$5 | 0.24% | 62 |
|
|
2016
Q1 | $394K | Sell |
300,833
-41,125
| -12% | -$53.9K | 0.27% | 55 |
|
|
2015
Q4 | $288K | Sell |
341,958
-101,743
| -23% | -$85.7K | 0.2% | 57 |
|
|
2015
Q3 | $399K | Buy |
443,701
+470
| +0.1% | +$423 | 0.24% | 52 |
|
|
2015
Q2 | $771K | Sell |
443,231
-4,148
| -0.9% | -$7.22K | 0.41% | 45 |
|
|
2015
Q1 | $904K | Sell |
447,379
-10,237
| -2% | -$20.7K | 0.46% | 43 |
|
|
2014
Q4 | $1.2M | Buy |
457,616
+6,784
| +2% | +$17.8K | 0.67% | 42 |
|
|
2014
Q3 | $1.12M | Sell |
450,832
-267
| -0.1% | -$665 | 0.72% | 41 |
|
|
2014
Q2 | $992K | Buy |
451,099
+11,037
| +3% | +$24.3K | 0.69% | 46 |
|
|
2014
Q1 | $1.06M | Buy |
440,062
+11,048
| +3% | +$26.6K | 0.77% | 45 |
|
|
2013
Q4 | $1.21M | Sell |
429,014
-35,963
| -8% | -$102K | 0.97% | 38 |
|
|
2013
Q3 | $889K | Sell |
464,977
-12,491
| -3% | -$23.9K | 0.81% | 39 |
|
|
2013
Q2 | $1.71M | Buy |
+477,468
| New | +$1.71M | 1.64% | 26 |
|